Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von ElectricPlayer 

Omega Healthcare Investors Inc. diskutieren

Omega Healthcare Investors Inc.

WKN: 890454 / Symbol: OHI / Name: Omega Healthcare / Aktie / REITs / Mid Cap /

35,85 €
-0,25 %

Buy Omega Healthcare Investors Inc.

Buy Omega Healthcare Investors Inc.

Einschätzung Sell
Rendite (%) 16,85 %
Kursziel 22,97
Veränderung
Endet am 31.03.24

Omega Healthcare Investors, Inc. (NYSE: OHI) had its "underperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $25.00 price target on the stock.
Ratings data for OHI provided by MarketBeat

Omega Healthcare Investors, Inc. (NYSE: OHI) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
Ratings data for OHI provided by MarketBeat

Einschätzung Buy
Rendite (%) 19,57 %
Kursziel 32,69
Veränderung
Endet am 08.09.24

Omega Healthcare Investors, Inc. (NYSE: OHI) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $31.00.
Ratings data for OHI provided by MarketBeat

Einschätzung Buy
Rendite (%) 18,09 %
Kursziel 33,64
Veränderung
Endet am 20.09.24

Omega Healthcare Investors, Inc. (NYSE: OHI) had its price target raised by analysts at Raymond James from $33.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for OHI provided by MarketBeat

Omega Healthcare Investors, Inc. (NYSE: OHI) was downgraded by analysts at BNP Paribas from a "neutral" rating to an "underperform" rating.
Ratings data for OHI provided by MarketBeat

Einschätzung Buy
Rendite (%) 34,19 %
Kursziel 31,16
Veränderung
Endet am 03.01.25

Omega Healthcare Investors, Inc. (NYSE: OHI) had its price target lowered by analysts at Mizuho from $35.00 to $34.00. They now have a "buy" rating on the stock.
Ratings data for OHI provided by MarketBeat

Einschätzung Buy
Rendite (%) 38,37 %
Kursziel 33,22
Veränderung
Endet am 30.01.25

Omega Healthcare Investors, Inc. (NYSE: OHI) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for OHI provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,66 %
Kursziel 32,23
Veränderung
Endet am 26.02.25

Omega Healthcare Investors, Inc. (NYSE: OHI) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $31.00.
Ratings data for OHI provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,88 %
Kursziel 32,31
Veränderung
Endet am 22.03.25

Omega Healthcare Investors, Inc. (NYSE: OHI) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $32.00.
Ratings data for OHI provided by MarketBeat

Omega Healthcare Investors, Inc. (NYSE: OHI) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Ratings data for OHI provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,83 %
Kursziel 41,50
Veränderung
Endet am 12.09.25

Hey there, fellow investor! I've been eyeing Omega Healthcare Investors (OHI) lately, and I've got to say, it's looking pretty tempting. Sure, there's been some insider selling, but let's not jump to conclusions. The healthcare REIT sector is looking robust, especially with potential interest rate cuts on the horizon. OHI's juicy 6.98% dividend yield is hard to ignore in this low-yield environment. Plus, with a diverse portfolio of senior housing and skilled nursing facilities across the US and UK, they're well-positioned to weather economic storms. The stock's recent performance has been impressive, outpacing many of its peers. While it's trading above its GF Value, the long-term prospects in healthcare real estate are compelling. It's like buying a piece of prime real estate in the 'silver tsunami' path – you know demand's only going to grow! However, keep an eye on those insider sales and occupancy rates. All in all, I'm feeling bullish on OHI. It might just be the prescription for a healthy portfolio!

Einschätzung Buy
Rendite (%) -1,97 %
Kursziel 38,85
Veränderung
Endet am 01.10.25

Omega Healthcare Investors, Inc. (NYSE: OHI) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $43.00 price target on the stock, up previously from $40.00.
Ratings data for OHI provided by MarketBeat